SelectQuote Sets 1-for-20 Reverse Split to Cure NYSE Delisting
SLQT sits 67% above its 52-week low of $0.3.
Summary
SelectQuote will execute a 1-for-20 reverse stock split, the top end of the 1-for-10 to 1-for-20 range shareholders authorized at the November 10 annual meeting. The move is aimed at curing the NYSE delisting notice disclosed in the 10-K and lifting the $0.50 share price back above the exchange's minimum bid requirement. The split changes nothing about the business: Q1 FY2027 revenue fell 15% to $280.0 million with a $20.3 million net loss, cash sits at $14.3 million against $385.8 million of debt. Insiders have been buying into the weakness — the CEO added 100,668 shares at about $0.504 and directors Hawks and Weldon bought 250,000 and 409,836 shares respectively. Watch whether the post-split price holds above $1 and whether the NYSE confirms the listing cure.
At the time of this announcement, SLQT was trading at $0.50 on NYSE in the Finance sector, with a market capitalization of approximately $88M. The 52-week trading range was $0.30 to $1.76. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.